Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

[Nle4, D-Phe7]-alpha-melanocyte stimulating hormone

EU orphan designation number: EU/3/08/541   
Active ingredient: [Nle4, D-Phe7]-alpha-melanocyte stimulating hormone
Indication: Treatment of erythropoietic protoporphyria
Sponsor: Clinuvel UK Limited
c/o - Reed Smith, Broadgate Tower, Third Floor, 20 Primrose Street, London, EC2A 2RS, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Scenesse on 22/12/2014 with the number EU/1/14/969

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/05/2008 Orphan Designation EMEA/OD/108/07 (2008)1898 of 08/05/2008
28/04/2009 Change of address of sponsor